SCHEMBL30587149

SCHEMBL30587149

Cc1cc(-c2nnc(-c3ccccc3)o2)ccc1N

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 14/20 0.61
RAB9A P51151 14/20 0.61
SMN1; SMN2 Q16637 12/20 0.61
HPGD P15428 7/20 0.61
POLB P06746 2/20 0.61
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
NFKB1 P19838 2/20 0.61
NFKB2 Q00653 2/20 0.61
RELA Q04206 2/20 0.61
TSHR P16473 7/20 0.60
MECP2 P51608 1/20 0.60
ALDH1A1 P00352 6/20 0.59
KDM4E B2RXH2 3/20 0.59
HSD17B10 Q99714 3/20 0.59
MAPT P10636 2/20 0.59
GLA P06280 1/20 0.59
ALOX15 P16050 1/20 0.59
MAOB P27338 1/20 0.58
TP53 P04637 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24473988 1.00 NPC1 (0.61) NPC1RAB9ASMN1; SMN2HPGDPOLB
SCHEMBL19859806 0.93 ALDH1A1 (0.59) NPC1RAB9ASMN1; SMN2HPGDPOLB
SCHEMBL24623120 0.91 ALDH1A1 (0.61) NPC1RAB9ASMN1; SMN2HPGDPOLB
SCHEMBL24623365 0.88 NPC1 (0.66) NPC1RAB9ASMN1; SMN2HPGDPOLB
SCHEMBL24474033 0.80 NPC1 (0.61) NPC1RAB9ASMN1; SMN2HPGDPOLB
SCHEMBL30587143 0.80 NPC1 (0.61) NPC1RAB9ASMN1; SMN2HPGDPOLB
SCHEMBL30587148 0.80 NPC1 (0.75) NPC1RAB9ASMN1; SMN2HPGDPOLB
SCHEMBL24474028 0.80 NPC1 (0.75) NPC1RAB9ASMN1; SMN2HPGDPOLB
SCHEMBL11479566 0.78 NPC1 (0.73) NPC1RAB9ASMN1; SMN2HPGDPOLB
SCHEMBL807858 0.78 TDP1 (0.77) NPC1RAB9ASMN1; SMN2HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116457353-A N-substituted 4- (5-phenyl-1, 3, 4-oxadiazol-2-yl) anilines for the treatment and prophylaxis of hepatitis b virus infections 豪夫迈·罗氏有限公司 2023-07-18 CN claimed
CN-116457353-A N-substituted 4- (5-phenyl-1, 3, 4-oxadiazol-2-yl) anilines for the treatment and prophylaxis of hepatitis b virus infections 豪夫迈·罗氏有限公司 2023-07-18 CN disclosed